The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
A phase 2 trial of Prosigna in Breast cancer, run by Dana-Farber Cancer Institute, active and no longer recruiting.
Overview
The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer is a phase 2 interventional study registered as NCT02653755 by Dana-Farber Cancer Institute, with 671 participants planned, started 2015-12-15 and due to reach its primary completion in 2030-05-15. Interventions recorded: Prosigna. Conditions recorded: Breast Cancer Radiation.
Linked to the drug Prosigna because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- Trial[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
Shares Breast cancer (all types) and the tag pipeline.
- TrialStudy on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialIntraoperative Radiotherapy for Korean Patients With Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.